Prevention of Syncope Trial (POST)
Jump to navigation
Jump to search
Introduction
Randomized, placebo-controlled study for patients with vasovagal syncope.
Treatment:
- metoprolol 25-200 mg daily vs placebo
Results:
- metoprolol of no benefit
More general terms
Additional terms
References
- ↑ Sheldon R et al, Prevention of Syncope Trial (POST): A randomized, placebo- controlled study of metoprolol in the prevention of vasovagal syncope Circulation 2006; 113:1164 PMID: https://www.ncbi.nlm.nih.gov/pubmed/16505178